Categories Analysis, Consumer

Main takeaways from Lamb Weston’s (LW) Q3 2025 earnings report

The company expects net sales to range between $6.35-6.45 billion for the full year

Shares of Lamb Weston Holdings, Inc. (NYSE: LW) jumped 9% on Thursday after the company delivered better-than-expected results for the third quarter of 2025 and reaffirmed its outlook for the full year. It also continues to generate cost savings from the restructuring plan it launched last year. Here are some of the main takeaways from the earnings report:

Revenue and earnings beat expectations

In Q3 2025, Lamb Weston’s net sales grew 4% year-over-year to $1.52 billion, beating estimates of $1.50 billion. Volume grew 9%, helped by the replacement of lost customer volume and recent customer contract wins. GAAP earnings per share rose 2% to $1.03 in the quarter. Adjusted EPS decreased 8% YoY to $1.10 but managed to surpass projections of $0.87.

Growth across segments

In Q3, Lamb Weston achieved sales and volume growth in both its business segments. The North America segment saw sales increase 4% YoY to $986.3 million. Volume in this segment increased 8% as the company replaced lost customer volume and won customer contracts across each of its channels.

Sales for the International segment rose 5% YoY to $534.2 million. Volumes rose 12%, led mainly by chain customer contract wins in key international markets. The volume gains were partly offset by impacts from the company’s exit from certain low-price, low-margin business in Europe last year.

During the quarter, LW’s volume gains were partly offset by softness in restaurant traffic, which the frozen potato products maker expects will continue to be a headwind.

Reaffirms outlook

Lamb Weston reaffirmed its outlook for fiscal year 2025. The company expects net sales to range between $6.35-6.45 billion and adjusted EPS to range between $3.05-3.20 for the year.

Listen to the conference calls as they happen. Don't miss a beat! With AlphaStreet Intelligence, you can listen to live calls and interviews as they happen, so you never have to worry about missing out on important information.

Most Popular

AbbVie Q1 2025 adjusted earnings increase on 8% revenue growth; beat estimates

Biopharmaceutical company AbbVie, Inc. (NYSE: ABBV) announced first-quarter 2025 financial results, reporting an increase in revenue and adjusted earnings. The company reported worldwide net revenues of $13.3 billion for the

Colgate-Palmolive (CL) Q1 2025 Earnings: Key financials and quarterly highlights

Colgate-Palmolive Company (NYSE: CL) reported its first quarter 2025 earnings results today. Net sales decreased 3.1% year-over-year to $4.9 billion. Organic sales growth was 1.4%. Net income attributable to Colgate-Palmolive Company rose

Meta Platforms (META) set to report Q1 earnings. Here’s what to expect

After integrating artificial intelligence into its products, Meta Platforms, Inc. (NASDAQ: META) is investing heavily in the metaverse project. Yet, the tech giant has maintained healthy cash flows and consistently

Add Comment
Loading...
Cancel
Viewing Highlight
Loading...
Highlight
Close